CYTK icon

Cytokinetics

127 hedge funds and large institutions have $266M invested in Cytokinetics in 2018 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 37 increasing their positions, 42 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

less call options, than puts

Call options by funds: $ | Put options by funds: $

12% less repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 42

15% less capital invested

Capital invested by funds: $315M → $266M (-$48.2M)

18% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 22

Holders
127
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$973K
Puts
$1.1M
Net Calls
Net Calls Change

Top Buyers

1 +$852K
2 +$591K
3 +$567K
4
Invesco
Invesco
Georgia
+$547K
5
Millennium Management
Millennium Management
New York
+$543K

Top Sellers

1 -$3.48M
2 -$2.55M
3 -$1.71M
4
TCM
Tekla Capital Management
Massachusetts
-$1.53M
5
Squarepoint
Squarepoint
New York
-$1.14M
Name Holding Trade Value Shares
Change
Change in
Stake
76
$184K
77
$171K
78
$162K
79
$157K
80
$138K
81
$137K
82
$135K
83
$135K
84
$133K
85
$121K
86
$119K
87
$117K
88
$109K
89
$105K
90
$101K
91
$101K
92
$98.7K
93
$81K
94
$80K
95
$78K
96
$77K
97
$73K
98
$72K
99
$44K
100
$28K